|
|
|
| 1. |
Mabuchi
H, Koizumi J, Shimizu M, Kajinami K, Miyamoto S, Ueda K, Takegoshi
T, and the Hokuriku-FH-LDL-Apheresis Study Group. Long-term
efficacy of low-density lipoprotein apheresis on coronary
heart disease in familial hypercholesterolemia. Am
J Cardiol 1998; 82:1489-1495.
 |
2. |
M.Matsuzaki,
K.Hiramori, T.Imaizumi, A. Kitabatake, H. Hishida, M. Nomura,
T. Fujii, I. Sakuma, K. Fukami, T. Honda, H. Ogawa, M. Yamagishi.
Intravascular Ultrasound Evaluation of Coronary Plaque
Regression by Low Density Lipoprotein-Apheresis in Familial
Hypercholesterolemia J Am Coll Cardiol 2002;40:220-227.
|
3. |
Tamai
0, Matsuoka H, ltabe H, Wada Y, Kohno K, lmaizumi T. Single
LDL apheresis improves endothelium-dependent vasodilation
in hypercholesterolemic humans. Circulation 1997;
95:76-82. |
|
4. |
Tamai
O., Matsuoka H., and Imaizumi T.:Improvement
of Endothelium-Dependent Vasodilatation in Hypercholesterolemic
Humans by Single LDL Apheresis Japanese Journal of
Apheresis. 1996;15:268-274. |
| 5. |
Otto C.,
Geiss H., Empen K., and Parhofer K.: Long-term reduction
of C-reactive protein concentration by regular LDL Apheresis.
Atherosclerosis 174 (2004) 151-156. |
| 6. |
Kobayashi
J., Katsube S., Shimoda M., Furuhashi K., Kitano S., Masuda
M., Maruyama T., and Shinomiya M.: Single LDL Apheresis
improves serum remnant-like particle-cholesterol, C-reactive
protein, and malondialdehyde-modified-low-density lipoprotein
concentrations in Japanese hypercholesterolemic subjects. Clinica
Chimica Acta 321 (2002) 107-112. |
| 7. |
Stefanutti
C., Lanti A., Di Giacomo S., Mareri M., De Lorenzo F., Landolfo
A., and Isacchi G.: Therapeutic apheresis in low weight
patients: technical feasibility, tolerance, compliance, and
risks. Transfusion and Apheresis Science 31(2004)
3-10. |
| 8. |
Igarashi
K., Tsuji M., Nishimura M., and Horimoto M.: Improvement
of Endothelium-Dependent Coronary Vasodilation After a Single
LDL Apheresis in Patients with Hypercholesteloremia.
Journal of Clinical Apheresis 2004;19:11-16. |
| 9. |
Kanemitsu
S., Takekoshi N., Matsui S., Tsugawa H., Ohkubo S., Kitayama
M., Matsuda T., Senma J., Masuyama K., Yamagata T., and Murakami
E.: Short-Term and Long-Term Effects of Low-Density
Lipoprotein (LDL) Apheresis on Restenosis after Percutaneous
Transluminal Coronary Angioplasty (PTCA): Is Lowering Lp(a)
by LDL Apheresis Effective on Restenosis after PTCA?
Therapeutic Apheresis 2(1): 65-70. |
| 10. |
Kanemitsu
S., Takekoshi N., and Murakami E.: Effects of LDL apheresis
on restenosis after angioplasty. |
| 11. |
Berliner
S., Ben-Ami R., Samocha-Bonet D., Abu-Abeid S., Schechner V.,
Beigel Y., Shapira I., Yedgar S., and Barshtein G.: The
Degree of red blood cell aggregation on peripheral blood glass
slides corresponds to inter-erythrocyte cohesive forces in laminar
flow. Thrombosis Research (2004) 114, 37-44. |
12. |
Stefanutti
C, Di Giacomo S, Vivenzio A, Isacchi G.C, Masella R, Caprari
P, et al. Acute and long-term effects of low-density lipoprotein
(LDL)-apheresis on oxidative damage to LDL and reducing capacity
of erythrocytes in patients with severe familial hypercholesterolaemia.
Clinical Science 2001; 100:191-198. |
13. |
Stefanutti
C, Di Giacomo S, Vivenzio A, Colloridi V, Bosco G, Berni A,
et al. Low-density lipoprotein apheresis in a patient aged
3.5 years. ACTA PAEDIATR 2001; 90:694-701. |
14. |
Takahashi
K, Kobayashi J, Bujo H, Takahashi M, Taira K, et al. Long-term
(14 years) Effect of LDL Apheresis on Obstructive Changes
in Aortocoronary Saphenous-vein Bypass Grafts in a Case of
Heterozygous Familial Hypercholesterolemia with the LDL Receptor
Proline664 to Leucine Mutation. Intern Med 2000;
39(10):804-809. |
15. |
Lepage
S, Nigon F, Bonnefont-Rousselot D, Assogba U, Goulinet S,
Chancharme L, et al. Oxidizability of Atherogenic Low-Density
Lipoprotein Subspecies in Severe Familial Hypercholesterolemia:
Impact of Long-Term Low-Density Lipoprotein Apheresis.
J Cardiovasc Pharmacol Therapeut 2000; 5(2):87-103. |
16. |
Nishimura
S, Sekiguchi M, et al. Effects of intensive lipid
lowering by low-density lipoprotein apheresis on regression
of coronary atherosclerosis in patients with familial hypercholesterolemia:
Japan Low Density Lipoprotein-Apheresis Coronary Atherosclerosis
Prospective Study (L-CAPS). Atherosclerosis 1999;
144: 409-417. |
17. |
Mabuchi
H, Koizumi J,Shimizu M, Kajinami K, Miyamoto S, Ueda K, Takegoshi
T, and the Hokuriku-FH-LDL-Apheresis Study Group. Long-term
efficacy of low-density lipoprotein apheresis on coronary
heart disease in familial hypercholesterolemia. Am
J Cardiol 1998; 82:1489-1495. |
18. |
Gordon
BR, Kelsey SF, Dau PC, Gotto AM Jr, Graham K, Illingworth
R, et al. Long-term effects of low-density lipoprotain
apheresis using an automated dextran sulfate cellulose adsorption
system. Am J Cardiol 1998; 81:407-411. |
19. |
Saku
K, Takeda Y, Jimi S, Okabe M, Shirai K, Nii T, et al.
Long-term effect of low-density lipoprotein apheresis in a
patient with heterozygous familial hypercholosterolemia: follow-up
study using coronary angiography. J Cardiol 1998;
31:239-245. |
20. |
Sampietro
T, Tuoni M, Ferdeghini M, Ciardi A, Marraccini P, Prontera C,
et al. Plasma cholesterol regulates soluble cell adhesion
molecule expression in familial hypercholesterolemia. Circulation
1997; 96:1381-1385. |
21. |
Koga
N. The retardation of progressin, stabilization, and regression
of coronary and carotid atherosclerosis by low-density lipoprotein
apheresis in patients with familial hypercholesterolemia.
Therap Apher 1997; 1:260-270. |
22. |
Kroon
AA, van der Asten WNJC, Stalenhoef AFH. Effect of apheresis
on low-density lipoprotein on peripheral vascular disease in
hypercholesterolemic patients with coronary artery disease.
Ann Intern Med 1996; 125:945-954. |
23. |
Kroon
AA, Aengavaeren WRM, van der Werf T, Uijen GNH, Reiber JHC,
Bruschke AVG, Atalenhoef AFH. LDL-Apheresis Atherosclerosis
Regression Study (LAARS): effect of agressive versus conventional
lipid lowering treatment on coronary atherosclerosis.
Circulation 1996; 93:1826-1835. |
24. |
Aengevaeren
WR, Kroon AA, Stalenhoef AF, Uijen GJ, van der Werf T. Low
density lipoprotein apheresis improves regional myocardial
perfusion in patients with hypercholesterolemia and extensive
coronary artery disease. LDL-Apheresis Atherosclerosis Regression
Study (LAARS). J Am Coll Cardiol 1996; 28:1696-1704. |
25. |
Gordon
BR, Saal SD. Current status of low density lipoprotein-apheresis
for the therapy of severe hyperlipidemia. Curr Opin Lipidol
1996; 7:381-384. |
26. |
Thompson
GR, Maher VMG, Mathews S, Kitano Y, Nenwirth C, Shortt MB, et
al. Familial Hypercholesterolemia Regression Study: a randomized
trial of low-density lipoprotein apheresis. Lancet
1995; 345:811-816. |
27. |
Uno
H, Ueki Y, Murashima J, Miyake S, Tominaga Y, Eguchi K, Yano
K. Removal of LDL from plasma by adsorption reduces adhesion
molecules on mononuclear cells in patients with arteriosclerosis
obliterance. Atherosclerosis 1995; 116:93-102. |
28. |
Gordon
BR, Saal SD. Advances in LDL-apheresis for the treatment
of severe hypercholesterolemia. Curr Opin Lipidol 1994;
5:69-73. |
29. |
Koizumi
J, Koizumi I, Uno Y, lnazu A, Kajinami K, Haraki T, et al. Reduction
of lipoprotein (a) by LDL-apheresis using a dextran sulfate
cellulose column in patients with familial hypercholesterolemia.
Atherosclerosis 1993; 100:65- 74. |
|
|
©
Copyright Kaneka Pharma America LLC 2006. All rights reserved.
The information
on this site is intended for U.S. residents only. |
|
